Investor Ideas #Potcasts 514, #Cannabis News and #Stocks on the Move; (TSX: $FIRE.TO) (TSX: $AH.TO) (CSE: $PULL.C) (CSE: $LOVE.C) (TSXV: $N.V)
Delta, Kelowna, BC, January 8, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/010821-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/01081FIRE-AH-PULL-LOVE-N.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we will be looking at a few public company announcements.
The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) announced that it has made its first shipment of medical cannabis to Australia in a private label transaction in which the Company's medical cannabis will be sold in 10-gram containers and will be distributed to patients across the country.
The Australian medical cannabis market was characterized by strong year-over-year growth in 2020. According to FreshLeaf Analytics' Australian Medicinal Cannabis Market Patient and Pricing Analysis for Q3 2020, the Australian medical cannabis market is expected to triple with regards to active patients and product sales measured by revenue.
The Company also completed its fourth shipment of calendar 2020 to Israel through the Company's partnership with Breath of Life International Ltd. ("BOL Pharma"), Israel's largest and leading producer of medical cannabis and cannabis products. This shipment was the largest to date of Jean Guy and Sensi Star strains, sold under the Truverra label.
"We are pleased to be introducing our medical cannabis to the Australian market," said Beena Goldenberg, President and CEO of Supreme Cannabis. "Having already completed shipments to Israel, our first sale into the Australian market is a meaningful step toward executing on our international medical strategy of creating additional wholesale medical partnerships in various international jurisdictions. We are committed to supplying high-quality medical cannabis to our partners; Australian patients will now be able to access our Jean Guy strain, which is a tribute to the legendary variety offered by the Montreal Compassion Club. We are impressed by the significant growth of the Australian medical cannabis market and we look forward to opportunities to expand our Australian partnership and help more Australian patients in 2021."
Aleafia Health Inc. (TSX: AH) (OTC: ALEAF) announced entering into a definitive three-year cannabis supply agreement with Apipharm Veletrgovina d.o.o. a leading European pharmaceutical producer and distributor.
Apipharm specializes in the distribution of active pharmaceutical ingredients of plant origin including semi-synthetic cannabinoid isolates, along with the development of advanced pharmaceutical formulations.
Under the terms of the agreement, Aleafia Health will supply Apipharm with dried cannabis flower grown at its Niagara greenhouse facility. Apipharm has also submitted an initial purchase order to Aleafia Health, for 1,000 kg of premium dried flower. The initial purchase order is expected to ship as early as the end of Q1 2021, dependent on the timing of necessary import and export permits.
“It is our great pleasure that we have entered into a partnership agreement with Aleafia which will strengthen our market position in the development of advanced pharmaceutical formulations,” said Dr. Matevz Pompe, CEO of Apiharm.
“We are delighted to open a new international sales channel leveraging the well-established distribution network and expertise of Apipharm,” said Aleafia Health CEO Geoffrey Benic. “Building on our best results to date in the most recent quarter, we will continue to execute on near-term international sales opportunities, fully leveraging our world class Canadian cannabis production assets.”
Pure Extracts Technologies Corp. (CSE: PULL)(OTC: PRXTF) announced that the Company received trading approval from OTC Markets and is now trading on the OTC Market under the ticker symbol PRXTF.
Pure Extracts CEO, Ben Nikolaevsky, remarked, “Trading under the new OTC ticker symbol PRXTF and applying for DTC eligibility is a major step forward in making it materially easier to welcome U.S.-based investors as new shareholders. This is an important step in amplifying our story to a wider audience and to grow our investor base.”
OTC Markets offer developing Canadian companies the benefits of being publicly traded in the U.S. with lower cost and complexity than a U.S. exchange listing. Streamlined market standards enable Canadian companies to provide a strong baseline of transparency to inform and engage U.S. investors. To be eligible, Canadian companies must be current in their SEDAR reporting and undergo an annual verification and management certification process. Pure Extracts shares will continue to trade on the Canadian Securities Exchange (CSE) under the symbol PULL, as well as the Frankfurt Stock Exchange under the symbol A2QJAJ.
Cannara Biotech Inc. (CSE: LOVE) (OTCQB: LOVFF) announced that, through its wholly-owned subsidiary, Cannara Biotech (Quebec) Inc., it has received approval from Health Canada to amend its license to permit the sale of dried cannabis products to provincially authorized distributors and retailers nationwide. As revenue steadily grows over the next 12 months, Cannara expects rapid growth in profitability and cashflow given its lean operating structure and production cost advantage.
"Within our home province of Quebec, demand for high quality Quebec-grown cannabis is strong and expanding rapidly," said Zohar Krivorot, President and Chief Executive Officer of Cannara. "The receipt of our sales licence from Health Canada is a significant milestone in our journey and will enable us to continue executing our plan to generate value for consumers and shareholders. We look forward to getting our brand portfolio into the hands of customers across the province of Quebec over the coming months."
Cannara indoor-grown cannabis is produced to the highest quality standards. As a result cannabis is cultivated from a bank of rare genetics, hang-dried, slow-cured, and hand-trimmed. The Company plans to initially launch three product lines:
● THC-dominant: Top-shelf genetics featuring hand-crafted cannabis with elevated THC and rich terpene profiles, available in 3.5 gram and pre-roll formats.
● CBD-dominant: Unique genetics containing less THC and more CBD available in 3.5 gram and pre-roll formats.
● High-value: Quality cannabis offered at an accessible price point in a 28 grams bulk format.
Namaste Technologies Inc. (TSXV: N)) (OTC: NXTTF), a leading platform for cannabis products, accessories, and education, announced the launch of its 2.0 consumer-focused recreational house brand "Roilty". Under the Roilty brand, Namaste's wholly owned subsidiary CannMart Inc. will launch new products such as live resin targeted to be available in February, followed by rosin, shatter, crumble and wax in successive quarters. Trademark for Roilty is pending approval.
Roilty:
● The focus of the new brand Roilty is specifically focused around 2.0 products. With the recent acquisition of CannMart Labs Inc., Namaste now has the capability to develop high quality products that are in high demand at a lower price than competitors. Roilty will be positioned as a high-end, accessible mainstream brand
● CannMart Labs facility in Ontario is completed for BHO extraction using leading extraction technology, making it one of only a few facilities in Canada with such capabilities
● Set to produce in-house branded Cannabis 2.0 products for medical channel customers available at CannMart.com and recreational customers across Canada through sister company CannMart's network of provincial sales partners
● Cannabis 2.0 products initially planned include vape cartridges, live resin and shatter, with capabilities to expand future product offerings to rosin, capsules, tinctures and edibles
Phyto 1-Gram Vape Cartridges:
CannMart to launch Phyto 1-gram vape carts, a product with high demand coupled with high margins. We anticipate a shift in consumer demand from 0.5-gram to 1-gram vape carts.
The following SKU's will be available in a 1-gram cartridge:
● Blueberry
● Pink Kush
● Grapefruit Haze
● Green Apple
A purchase order from a province has just been received for two of our best-selling strains, Blueberry and Pink Kush. Grapefruit Haze and Green Apple are two new strains based on consumer demand feedback.
"We are excited for the launch of our in-house brand "Roilty" as we see an increasing demand for additional 2.0 products with a strong value proposition," said Meni Morim, CEO of Namaste. "We are working hard towards receiving our processing licence from Health Canada and look forward to producing our in house branded Cannabis 2.0 products, for our medical channel customers at CannMart.com and recreational consumers across Canada through our network of provincial sales partners. We are clearly focused on the execution of our strategy to position Namaste as a leading cannabis company and look forward to building on this positive momentum in 2021."
CannTrust Holdings Inc. announced it is re-entering the Canadian medical cannabis market today with its new medical brand estoraTM and will begin serving patients immediately.
estoraTM builds on CannTrust's foundation of consistent, high quality products, with a focus on providing superior patient care in every interaction, connecting patients, health care practitioners and partners with the educational resources and products they need to navigate each patient's unique medical cannabis journey.
"Since our inception, we have been dedicated to providing Canadians with consistently high-quality medical cannabis," said Greg Guyatt, Chief Executive Officer at CannTrust. "We're delighted to be launching our new medical brand estoraTM with a portfolio of medical cannabis products including oil drops, capsules and dried flower formats."
Many products are available for sale immediately through the newly launched ecommerce site www.estoramedical.com.
"We believe it was imperative to evolve our strong foundation in medical cannabis to meet the changing needs of our patients," said Guyatt. "estora™ has patient care at its core. We consulted patients and health care practitioners, learning more about their needs and refining our processes and product offerings to elevate their experience with us."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
